Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference, 4th edition, 372 pages

+ the daily Top 10

  Gastric Cancer

  Free Subscription

Articles published in Cancer

Retrieve available abstracts of 26 articles:
HTML format

Single Articles

    February 2020
  1. SUH YS, Lee J, Woo H, Shin D, et al
    National cancer screening program for gastric cancer in Korea: Nationwide treatment benefit and cost.
    Cancer. 2020 Feb 7. doi: 10.1002/cncr.32753.
    PubMed     Abstract available

    January 2020
  2. TIAN S, Jiang R, Madden NA, Ferris MJ, et al
    Survival outcomes in patients with gastric and gastroesophageal junction adenocarcinomas treated with perioperative chemotherapy with or without preoperative radiotherapy.
    Cancer. 2020;126:37-45.
    PubMed     Abstract available

    December 2019
  3. THIELS CA, Hanson KT, Habermann EB, Boughey JC, et al
    Integrated cancer networks improve compliance with national guidelines and outcomes for resectable gastric cancer.
    Cancer. 2019 Dec 10. doi: 10.1002/cncr.32660.
    PubMed     Abstract available

    July 2019
  4. SHAO D, Vogtmann E, Liu A, Qin J, et al
    Microbial characterization of esophageal squamous cell carcinoma and gastric cardia adenocarcinoma from a high-risk region of China.
    Cancer. 2019 Jul 29. doi: 10.1002/cncr.32403.
    PubMed     Abstract available

  5. CLEARY JM, Horick NK, McCleary NJ, Abrams TA, et al
    FOLFOX plus ziv-aflibercept or placebo in first-line metastatic esophagogastric adenocarcinoma: A double-blind, randomized, multicenter phase 2 trial.
    Cancer. 2019;125:2213-2221.
    PubMed     Abstract available

    June 2019
  6. GREALLY M, Agarwal R, Ilson DH
    Optimal management of gastroesophageal junction cancer.
    Cancer. 2019;125:1990-2001.
    PubMed     Abstract available

    May 2019
  7. SHARMA MR, Joshi SS, Karrison TG, Allen K, et al
    A UGT1A1 genotype-guided dosing study of modified FOLFIRINOX in previously untreated patients with advanced gastrointestinal malignancies.
    Cancer. 2019;125:1629-1636.
    PubMed     Abstract available

    April 2019
  8. MA G, Liu H, Du M, Zhang G, et al
    A genetic variation in the CpG island of pseudogene GBAP1 promoter is associated with gastric cancer susceptibility.
    Cancer. 2019 Apr 5. doi: 10.1002/cncr.32081.
    PubMed     Abstract available

    March 2019
  9. HUANG J, Mo H, Zhang W, Chen X, et al
    Promising efficacy of SHR-1210, a novel anti-programmed cell death 1 antibody, in patients with advanced gastric and gastroesophageal junction cancer in China.
    Cancer. 2019;125:742-749.
    PubMed     Abstract available

    January 2019
  10. MONDACA S, Janjigian YY
    Application of positron emission tomography imaging to personalize esophagogastric cancer care.
    Cancer. 2019 Jan 22. doi: 10.1002/cncr.31940.

    February 2018
  11. IKOMA N, Cormier JN, Feig B, Du XL, et al
    Racial disparities in preoperative chemotherapy use in gastric cancer patients in the United States: Analysis of the National Cancer Data Base, 2006-2014.
    Cancer. 2018 Feb 2. doi: 10.1002/cncr.31155.
    PubMed     Abstract available

    January 2018
  12. NEUWIRTH MG, Bierema C, Sinnamon AJ, Fraker DL, et al
    Trends in major upper abdominal surgery for cancer in octogenarians: Has there been a change in patient selection?
    Cancer. 2018;124:125-135.
    PubMed     Abstract available

    December 2017
  13. JIM MA, Pinheiro PS, Carreira H, Espey DK, et al
    Stomach cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.
    Cancer. 2017;123 Suppl 24:4994-5013.
    PubMed     Abstract available

  14. MOKDAD AA, Ali A, Yopp AC, Polanco PM, et al
    Adoption of evidence-based novel therapies in the treatment of gastric cancer: A national observational study.
    Cancer. 2017 Dec 6. doi: 10.1002/cncr.31179.
    PubMed     Abstract available

  15. WANG P, Sun Z, Wang W, Deng J, et al
    Conditional survival of patients with gastric cancer who undergo curative resection: A multi-institutional analysis in China.
    Cancer. 2017 Dec 4. doi: 10.1002/cncr.31160.
    PubMed     Abstract available

    October 2017
  16. LEVI Z, Kark JD, Twig G, Katz L, et al
    Body mass index at adolescence and risk of noncardia gastric cancer in a cohort of 1.79 million men and women.
    Cancer. 2017 Oct 20. doi: 10.1002/cncr.31049.
    PubMed     Abstract available

  17. STUMPF PK, Amini A, Jones BL, Koshy M, et al
    Reply to Tumor localization may change the type of adjuvant treatment in gastric cancer.
    Cancer. 2017 Oct 5. doi: 10.1002/cncr.31018.

  18. TEZ M, Altundag K
    Tumor localization may change the type of adjuvant treatment in gastric cancer.
    Cancer. 2017 Oct 5. doi: 10.1002/cncr.31021.

    September 2017
  19. STUMPF PK, Amini A, Jones BL, Koshy M, et al
    Adjuvant radiotherapy improves overall survival in patients with resected gastric adenocarcinoma: A National Cancer Data Base analysis.
    Cancer. 2017;123:3402-3409.
    PubMed     Abstract available

    August 2017
  20. MEDHANIE GA, Fedewa SA, Adissu H, DeSantis CE, et al
    Cancer incidence profile in sub-Saharan African-born blacks in the United States: Similarities and differences with US-born non-Hispanic blacks.
    Cancer. 2017;123:3116-3124.
    PubMed     Abstract available

  21. MASTELLARO MJ, Seidinger AL, Kang G, Abrahao R, et al
    Contribution of the TP53 R337H mutation to the cancer burden in southern Brazil: Insights from the study of 55 families of children with adrenocortical tumors.
    Cancer. 2017;123:3150-3158.
    PubMed     Abstract available

  22. FITZGERALD TL, Efird JT, Bellamy N, Russo SM, et al
    Perioperative chemotherapy versus postoperative chemoradiotherapy in patients with resectable gastric/gastroesophageal junction adenocarcinomas: A survival analysis of 5058 patients.
    Cancer. 2017;123:2909-2917.
    PubMed     Abstract available

    May 2017
  23. CATENACCI DV, Ang A, Liao WL, Shen J, et al
    MET tyrosine kinase receptor expression and amplification as prognostic biomarkers of survival in gastroesophageal adenocarcinoma.
    Cancer. 2017;123:1061-1070.
    PubMed     Abstract available

    March 2017
  24. STIEKEMA A, Van de Vijver KK, Boot H, Broeks A, et al
    Human epididymis protein 4 immunostaining of malignant ascites differentiates cancer of Mullerian origin from gastrointestinal cancer.
    Cancer. 2017;125:197-204.
    PubMed     Abstract available

    January 2017
  25. BEKAII-SAAB T, El-Rayes B
    Identifying and targeting cancer stem cells in the treatment of gastric cancer.
    Cancer. 2017 Jan 24. doi: 10.1002/cncr.30538.
    PubMed     Abstract available

  26. PRINTZ C
    Cancer mortality rates vary among specific Asian American ethnic groups.
    Cancer. 2017;123:11.

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.